• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    I

    Institut National de la Transfusion Sanguine

    EST. 1994
    1,292论文总数
    3.5万引用总数

    论文量&引用量时间轴

    机构学者

    论文(1292)

    年份
    起
    –
    止
    排序
    1Patterns and Trends of Antimicrobial Resistance in Bacterial Isolates from Urine Cultures in Eritrea, 2010–2021: a Secondary Dataset Analysis
    Eyob Yohannes Garoy, Matiwos Araya Ghebrehiwet, Nahom Fessehaye,Oliver Okoth Achila, Ghirmay Yemane Gebrehiwet, Feven Gebremeskel Abraham, Sador Daniel Berhe, Yonatan Laine Berhe,Samuel Tekle Mengistu, Abrehet Marikos Buthuamlak, Biniam Efrem Syum,Mohammed Elfatih Hamida

    Although the threat posed by antimicrobial resistance (AMR) in urinary tract infections (UTI) is well documented; significant knowledge gaps remain for most countries in Sub Saharan Africa. In this study, we aimed to describe the most common uropathogens in Eritrea. The magnitude, trends, and factors associated with AMR and multidrug-resistance (MDR) were also assessed. A retrospective record review of data (January 2010 – 2021) collected from all urine samples from patients from multiple treatment centers in Eritrea and analyzed at the microbiology department at the National Reference Laboratory (NHL) was undertaken. SPSS was used for statistical analysis, and Microsoft Excel was used to plot figures. A total of 2,999 isolates were recovered from 2010 to 2021. Of these, 91

    2026BMC Infectious Diseases(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Hepatitis B Virus Infection with High HBsAg and Undetectable DNA Levels in Untreated Blood Donors: Viral Mechanisms and Transfusion Safety Implications
    Maelenn Païline Delcourt,Marion Vermeulen,Aneta Kopacz,Manuela Miletic, Andrew Saville,Christoph Niederhauser,Jean-Michel Pawlotsky,Syria Laperche,Daniel Candotti

    BACKGROUND:Blood donor screening occasionally identifies individuals with high HBV surface antigen (HBsAg) levels despite undetectable or extremely low HBV DNA. Molecular basis and transfusion risk of this discordant profile remain unclear. STUDY DESIGN AND METHODS:Seventy-five blood donors with HBsAg >100 IU/mL and undetectable or very low HBV DNA (<6 IU/mL), including 39 ID-NAT-nonreactive, were investigated. HBV DNA was further assessed using a second ID-NAT assay, confirmatory PCR following virion concentration, and sequencing. Sequences were compared with those from genotype-matched high-viremia controls. Selected basic core promoter (BCP) and core mutations were introduced into 1.18-mer replication-competent Hepatitis B virus (HBV) plasmids to assess effects on extracellular virion-associated DNA production. RESULTS:Four (5%) samples were nonreactive by the two ID-NAT assays. HBV DNA was confirmed in all donors, often at unquantifiable levels, and all were anti-HBc positive. No consistent molecular signature was identified. Heterogeneous, case-specific mutations were detected in BCP, core, and PreS1, including variants predicted to affect pregenomic RNA transcription, encapsidation, or virion assembly, with no evidence of impaired polymerase activity. In vitro, selected BCP mutations significantly reduced extracellular HBV DNA without affecting HBsAg production. Most core mutations had minimal impact, although two strains carrying cN92T/cM93T or cS170F showed reduced virion-associated DNA. Some constructs exhibited impaired virion secretion or increased naked capsid production. CONCLUSION:HBsAg-positive/low-DNA profile largely reflects chronic inactive infection with minimal viremia. Diverse regulatory and structural mutations may contribute in a multifactorial manner. Persistent viral genomes and residual replication support continued HBsAg screening where NAT sensitivity is suboptimal and anti-HBc testing cannot be implemented.

    2026Transfusion(2026)
    引用
    AI阅读
    加入学术空间
    3Association of Hypertension and Genetic Variants in MYH9 and BMPR1B with Increased Proteinuria in Sickle Cell Disease.
    El Hadji Malick Ndour,Khuthala Mnika, El Hadj Ousmane Sene,Fatou Gueye Tall,Victoria Nembaware,Indou Deme Ly,Moussa Seck, Mara Sokhna, Rokhaya Dione, Coumba Kamby, Jean Pascal Demba Diop, Serigne Saliou Mbacke,

    BACKGROUND:Sickle cell nephropathy (SCN) is a major chronic complication of sickle cell disease, and its progression may be influenced by genetic factors. This study aimed to investigate the association between variants in the MYH9 and BMPR1B genes and increased total proteinuria in patients with sickle cell anemia. MATERIALS AND METHODS:This cross-sectional study included patients with homozygous (SS) sickle cell disease who were followed up in Dakar. Urinary albumin, total proteins, and creatinine levels, along with serum creatinine and urea concentrations, were measured. Genotyping of the single nucleotide variants MYH9-rs4821469, MYH9-rs3752462, MYH9-rs2032487, and BMPR1B-rs17022863 was performed using mass spectrometry (MassARRAY technology). Associations were evaluated using multivariate logistic regression analysis. RESULTS:The 150-patient cohort had a mean age of 20.44 ± 9.86 years, with a slight female majority (51 %). A high prevalence of increased total proteinuria (urine proteins-to-creatinine ratio ≥150 mg/g) was observed, affecting 50.67 % of this young population. Multivariate analysis identified relative systemic hypertension (blood pressure ≥130/80 mmHg) as a powerful and independent risk factor for increased total proteinuria. While an initial analysis suggested a protective association for the MYH9 - rs4821469 variant, this signal was unstable and lost statistical significance in more stringent models. CONCLUSION:Increased total proteinuria is highly prevalent in this young cohort, indicating early onset of kidney damage. Relative systemic hypertension is a major modifiable risk factor, underscoring the need for rigorous blood pressure control. The instability of the initial genetic signal for MYH9-rs4821469, coupled with its strong linkage disequilibrium with APOL1, suggests that the observed association is likely confounded by ungenotyped APOL1 variants. This highlights the critical importance of including APOL1 analysis in future SCN genetic studies in African-ancestry populations.

    2025Clinical biochemistry(2025)引用:23
    引用
    AI阅读
    加入学术空间
    4Major Blood Stream Infection-Causing Bacterial Pathogens, Antimicrobial Resistance Patterns and Trends: a Multisite Retrospective Study in Asmara, Eritrea (2014–2022)
    Yosan Gebremeskel Andemichael, Eyorusalem Tsehaye Habtetsion, Hagos Hayelom Gulbet, Maedn Hailemariam Eman,Oliver Okoth Achila,Samuel Tekle Mengistu, Azania Werede Andemichael, Abrehet Marikos Buthuamlak,Eyob Yohannes Garoy,Berhe Tesfai,Mohammed Elfatih Hamida

    An important knowledge gap exists on the epidemiology of blood stream infections (BSIs) in low-middle-income countries (LMICs). In this retrospective analysis, we evaluated the etiology, antimicrobial resistance (AMR) and trends of BSIs in Eritrea. The study reviewed 9-year records (January 2014– December 2022) of 3153 patients with blood culture results available in the National Health Laboratory (NHL) archives. Relevant data included age, sex, hospital/care center, and year. During the surveillance period, we examined data from 3153 patients (1797 (57.0

    2025Annals of Clinical Microbiology and Antimicrobials(2025)引用:2
    引用
    AI阅读
    加入学术空间
    5Skin Reactions and Other Underappreciated Dermatologic Side Effects of Cancer Therapies.
    Hue T. T. Tran, Thuy M. Tran, Duc V. Le, Jena C. Jacobs, Trang M. Nguyen, Huy L. Trinh, Binh T. T. Vo, Tung S. Tran, Giang H. Nguyen

    Cutaneous adverse events (cAEs) are among the most common toxicities associated with modern cancer therapies, which are particularly heightened among immunotherapies and targeted agents. Despite being frequently immune-mediated, the majority of cAEs are mild to moderate and can be effectively managed without interruption of anticancer treatment. In immunotherapies-receiving patients, common phenotypes of cAEs include eczema-like, lichenoid, psoriasiform, vitiligo-like, and bullous eruptions. Targeted therapies including epidermal growth factor receptor inhibitors, BRAF inhibitors/MEK inhibitors, and phosphoinositide 3-kinase inhibitors are frequently associated with papulopustular eruptions, xerosis, paronychia, and photosensitivity. Mechanistically, cAEs may result from on-target immune activation, which correlates with treatment efficacy, or off-target hypersensitivity. Notably, certain phenotypes such as vitiligo, alopecia areata, and lichenoid reactions have been associated with improved survival in melanoma and non-small cell lung cancer. Management is guided based on the Common Terminology Criteria for Adverse Events grading, emphasizing the role of topical therapies for mild cases, systemic corticosteroids or immunosuppressants for moderate-to-severe reactions, and biologic or novel topical agents for steroid-refractory disease. By timely and appropriate intervention, most cAEs are manageable and may carry favorable prognostic significance. Early dermatologic collaboration is essential to reduce morbidity and ensure uninterrupted oncologic therapy.

    2025Current Treatment Options in Oncology(2025)引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1292 篇论文

    合作机构(100)

    巴黎医院公共援助合作论文 55
    法国国家健康与医学研究院合作论文 54
    Établissement Français du Sang合作论文 23
    里昂大学合作论文 18
    巴黎大学合作论文 16
    Institut de Veille Sanitaire合作论文 11
    Necker–Enfants Malades Hospital合作论文 10
    巴斯德研究所合作论文 9
    索瓦巴女王纪念研究所合作论文 9
    法国国家科学研究中心合作论文 8

    机构统计